Firefly Neuroscience, Inc. (AIFF)

Firefly Neuroscience Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	4.33	1.81	2.14	0.06	0.65
Cash & Short-Term Investments	4.33	1.81	2.14	0.06	0.65
Cash Growth	251.63%	-15.54%	3594.83%	-91.12%	-
Accounts Receivable	0.18	0.12	0.08	-	-
Other Receivables	-	-	-	0.02	0.04
Receivables	0.18	0.12	0.08	0.02	0.04
Prepaid Expenses	0.18	0.28	0.03	0.01	0.01
Other Current Assets	0.66	0.42	-	-	-
Total Current Assets	5.43	2.63	2.26	0.08	0.7
Property, Plant & Equipment	0.24	0.14	-	-	0.19
Other Intangible Assets	0.9	0.18	0.39	-	0
Long-Term Deferred Charges	0.37	0.97	-	-	-
Other Long-Term Assets	0.3	0.68	-	0.05	0.06
Total Assets	12.41	4.6	2.64	0.14	0.95
Accounts Payable	1.35	1.82	0.63	0.42	0.5
Accrued Expenses	0.66	1.63	1.9	0.86	0.75
Short-Term Debt	-	0.69	-	0.18	2.26
Current Unearned Revenue	0.24	0.01	-	0.91	0.46
Other Current Liabilities	0.48	0.83	-	-	-
Total Current Liabilities	2.72	4.98	2.53	2.36	3.97
Total Liabilities	2.75	4.98	2.53	2.36	3.97
Additional Paid-In Capital	118.55	86.71	76.73	71.8	61.89
Retained Earnings	-108.9	-87.08	-76.62	-74.02	-67.33
Total Common Equity	9.66	-0.38	0.11	-2.23	-5.44
Shareholders' Equity	9.66	-0.38	0.11	-2.23	-3.01
Total Liabilities & Equity	12.41	4.6	2.64	0.14	0.95
Total Debt	-	0.69	-	0.18	2.26
Net Cash (Debt)	4.33	1.12	2.14	-0.12	-1.6
Net Cash Growth	251.63%	-47.92%	-	-	-
Net Cash Per Share	0.39	0.17	0.66	-0.09	-
Filing Date Shares Outstanding	13.48	11.62	35.37	2.55	-
Total Common Shares Outstanding	13.48	8.12	35.37	2.55	-
Working Capital	2.71	-2.35	-0.28	-2.28	-3.26
Book Value Per Share	0.72	-0.05	0.00	-0.87	-
Tangible Book Value	3.58	-0.56	-0.28	-2.23	-5.44
Tangible Book Value Per Share	0.27	-0.07	-0.01	-0.87	-
Machinery	0.28	0.15	-	-	3.98

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q